Evaluation of a Mobile Digital Solution for Cancer Care and Research

Sponsor
Saint John's Cancer Institute (Other)
Overall Status
Completed
CT.gov ID
NCT03094741
Collaborator
CancerLife (Other)
30
1
1
43.2
0.7

Study Details

Study Description

Brief Summary

The primary purpose of this pilot study is to evaluate the feasibility and acceptability of a Mobile Digital Solution in monitoring and collecting symptom burden data. The proposed study is meant to be the preparatory work for an intervention study to test the effect of Mobile Digital Solutions on improving patient outcomes by prompting early interventions for symptom relief and support of patient and family caregiver quality of life (QOL).

Condition or Disease Intervention/Treatment Phase
  • Other: CancerLife
N/A

Detailed Description

Demographic information and patient-reported symptoms will be collected from study participants through a mobile health application called CancerLife that they can download (FREE) from their mobile device app store (Android or iOS). Participants will be asked to broadcast their emotional and physical status through a list of symptom list within the app as well as how that symptom is impacting their quality of life and activities of daily living. This data will be collected inside the application and display in easy to understand pie charts. Participants will also have the option to broadcast their entry to their social network.

Since the objective of the current feasibility study is to evaluate the feasibility and acceptability of a Mobile Digital Solution in monitoring and collecting symptom burden and QOL data, the investigators will include a standard validated instrument (FACT-G: Functional Assessment of Cancer Therapy - General) as part of this study. Participants will be asked to complete the FACT-G after initial registration and weekly for up to 4 weeks. Participants will receive electronic mail messages with a link to CancerLife weekly as a reminder to access the website.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Evaluation of a Mobile Digital Solution for Cancer Care and Research: A Feasibility Study
Actual Study Start Date :
Apr 1, 2017
Actual Primary Completion Date :
Sep 4, 2020
Actual Study Completion Date :
Nov 5, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: CancerLife Feasibility Group

Participants will be recruited through advertisements targeted to a specific audience using the keywords cancer and cancer survivors

Other: CancerLife
CancerLife is a mobile digital solution that allows patients to broadcast their health status inside a private invitation only group, text, email or publicly in Facebook or Instagram. By doing, so the patient collects his/her own patient-reported outcomes data and then share this data with their doctor or care team.

Outcome Measures

Primary Outcome Measures

  1. Feasibility/ Participation Rate [4 weeks]

    number of individuals who participate in the study divided by the number of individuals who opened the link

Secondary Outcome Measures

  1. Open Rate [4 weeks]

    number of individuals who open the link divided by total number of individuals reached by the advertisement

  2. Refusal rate [4 weeks]

    number of individuals who declined to participate divided by the number of individuals who opened the link

  3. Retention rate [4 weeks]

    number of mission data divided by total number of items available

  4. Rate of missing data [4 weeks]

    number of mission data divided by total number of items available

  5. Participant Satisfaction [4 weeks]

    describe the usability, satisfaction, and desirability of the Mobile Digital Solution using a patient experience survey at the end of the study

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Established diagnosis of cancer

  • Karnofsky Index ≥50%

  • Age > 18 years

Exclusion Criteria:
  • Relevant cognitive impairment

  • Insufficient knowledge of English language to complete the survey

Contacts and Locations

Locations

Site City State Country Postal Code
1 John Wayne Cancer Institute at Providence Saint John's Health Center Santa Monica California United States 90404

Sponsors and Collaborators

  • Saint John's Cancer Institute
  • CancerLife

Investigators

  • Study Chair: Santosh Kesari, MD, PhD, Saint John's Cancer Institute

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Saint John's Cancer Institute
ClinicalTrials.gov Identifier:
NCT03094741
Other Study ID Numbers:
  • JWCI-17-0301
First Posted:
Mar 29, 2017
Last Update Posted:
Feb 9, 2021
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Feb 9, 2021